ABSTRACT
Magnetic resonance cholangiopancreatography (MRCP), widely regarded as the non-invasive gold standard for evaluating the pancreatobiliary system, provides diagnostic accuracy comparable to that of endoscopic retrograde cholangiopancreatography. The aim of this review is to comprehensively discuss most recent MRCP protocol, relative advantages of 1.5T and 3T, characteristic imaging findings of common hepatobiliary pathologies, and method-specific pitfalls and limitations. State-of-the-art techniques, including breath-hold fast three-dimensional MRCP, as well as T1-weighted contrast-enhanced MRCP using hepatobiliary contrast agents, are addressed in detail. Additionally, pivotal imaging findings for diagnosis and differential diagnosis of conditions such as choledocholithiasis, benign and malignant biliary strictures, and intrabiliary rupture of hydatid cysts are highlighted. In conclusion, optimized imaging protocols and technological advances enable MRCP to be performed in shorter acquisition times without compromising image quality, thereby sustaining its critical role in the diagnosis and management of hepatobiliary diseases.
Keywords:
Biliary tract diseases, cholangiopancreatography, magnetic resonance, diffusion weighted imaging, contrast media
References
1
Becker CD, Grossholz M, Mentha G, de Peyer R, Terrier F. MR cholangiopancreatography: technique, potential indications, and diagnostic features of benign, postoperative, and malignant conditions. Eur Radiol. 1997; 7: 865-74.
2
Griffin N, Charles-Edwards G, Grant LA. Magnetic resonance cholangiopancreatography: the ABC of MRCP. Insights Imaging. 2012; 3: 11-21.
3
Vitellas KM, Keogan MT, Spritzer CE, Nelson RC. MR cholangiopancreatography of bile and pancreatic duct abnormalities with emphasis on the single-shot fast spin-echo technique. Radiographics. 2000; 20: 939-57; quiz 1107-8, 12.
4
Bishay K, Meng ZW, Khan R, Gupta M, Ruan Y, Vaska M, et al. Adverse events associated with endoscopic retrograde cholangiopancreatography: systematic review and meta-analysis. Gastroenterology. 2025; 168: 568-86.
5
Vidal BPC, Lahan-Martins D, Penachim TJ, Rodstein MAM, Cardia PP, Prando A. MR cholangiopancreatography: what every radiology resident must know. Radiographics. 2020; 40: 1263-64.
6
Ippolito D, Maino C, Arrivé L, Ba-Ssalamah A, Cannella R, Furlan A, et al. ESGAR consensus statement on MR imaging in primary sclerosing cholangitis. Eur Radiol. 2025; 35: 6495-506.
7
Manes G, Paspatis G, Aabakken L, Anderloni A, Arvanitakis M, Ah-Soune P, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019; 51: 472-91.
8
Guo X, Fan Q, Guo Y, Li X, Hu J, Wang Z, et al. Clinical study on the necessity and feasibility of routine MRCP in patients with cholecystolithiasis before LC. BMC Gastroenterol. 2024; 24: 28.
9
Hecht EM, Wang ZJ, Kambadakone A, Griesemer AD, Fowler KJ, Heimbach JK, et al. Living donor liver transplantation: preoperative planning and postoperative complications. AJR Am J Roentgenol. 2019; 213: 65-76.
10
Testa G, Nadalin S, Klair T, Florman S, Balci D, Frola C, et al. Optimal surgical workup to ensure safe recovery of the donor after living liver donation - a systematic review of the literature and expert panel recommendations. Clin Transplant. 2022; 36: e14641.
11
Kaltenthaler EC, Walters SJ, Chilcott J, Blakeborough A, Vergel YB, Thomas S. MRCP compared to diagnostic ERCP for diagnosis when biliary obstruction is suspected: a systematic review. BMC Med Imaging. 2006; 6: 9.
12
Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med. 2003; 139: 547-57.
13
Dave M, Elmunzer BJ, Dwamena BA, Higgins PD. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. Radiology. 2010; 256: 387-96.
14
Schindera ST, Merkle EM. MR cholangiopancreatography: 1.5T versus 3T. Magn Reson Imaging Clin N Am. 2007; 15: 355-64.
15
Isoda H, Kataoka M, Maetani Y, Kido A, Umeoka S, Tamai K, et al. MRCP imaging at 3.0 T vs. 1.5 T: preliminary experience in healthy volunteers. J Magn Reson Imaging. 2007; 25: 1000-6.
16
Arizono S, Isoda H, Maetani YS, Hirokawa Y, Shimada K, Nakamoto Y, et al. High spatial resolution 3D MR cholangiography with high sampling efficiency technique (SPACE): comparison of 3T vs. 1.5T. Eur J Radiol. 2010; 73: 114-8.
17
Almehdar A, Chavhan GB. MR cholangiopancreatography at 3.0 T in children: diagnostic quality and ability in assessment of common paediatric pancreatobiliary pathology. Br J Radiol. 2013; 86: 20130036.
18
Patel HT, Shah AJ, Khandelwal SR, Patel HF, Patel MD. MR cholangiopancreatography at 3.0 T. Radiographics. 2009; 29: 1689-706.
19
Welle CL, Miller FH, Yeh BM. Advances in MR imaging of the biliary tract. Magn Reson Imaging Clin N Am. 2020; 28: 341-52.
20
Glenn A, Trout AT, Kocaoglu M, Ata NA, Crotty EJ, Tkach JA, et al. Patient- and examination-related predictors of 3D MRCP image quality in children. AJR Am J Roentgenol. 2022; 218: 910-6.
21
Tirkes T, Sandrasegaran K, Sanyal R, Sherman S, Schmidt CM, Cote GA, et al. Secretin-enhanced MR cholangiopancreatography: spectrum of findings. Radiographics. 2013; 33: 1889-906.
22
Frisch A, Walter TC, Hamm B, Denecke T. Efficacy of oral contrast agents for upper gastrointestinal signal suppression in MRCP: a systematic review of the literature. Acta Radiol Open. 2017; 6: 2058460117727315.
23
Ozturkmen Akay H, Karadeniz Bilgili MY. Pankreas MR görüntüleme çekim protokolleri. Trd Sem. 2019; 7: 111-28.
24
Guibaud L, Bret PM, Reinhold C, Atri M, Barkun AN. Bile duct obstruction and choledocholithiasis: diagnosis with MR cholangiography. Radiology. 1995; 197: 109-15.
25
Tan CK, Wong MK, Khan KS. Unveiling hidden diagnoses: the prevalence and clinical impact of extra-biliary findings on magnetic resonance cholangiopancreatography. Cureus. 2025; 17: e92236.
26
Yoo RE, Lee JM, Yoon JH, Kim JH, Han JK, Choi BI. Differential diagnosis of benign and malignant distal biliary strictures: value of adding diffusion-weighted imaging to conventional magnetic resonance cholangiopancreatography. J Magn Reson Imaging. 2014; 39: 1509-17.
27
Sohns JM, Staab W, Dabir D, Spiro JE, Bergau L, Schwarz A, et al. Current role and future potential of magnetic resonance cholangiopancreatography with an emphasis on incidental findings. Clin Imaging. 2014; 38: 35-41.
28
Canellas R, Rosenkrantz AB, Taouli B, Sala E, Saini S, Pedrosa I, et al. Abbreviated MRI protocols for the abdomen. Radiographics. 2019; 39: 744-58.
29
Tso DK, Almeida RR, Prabhakar AM, Singh AK, Raja AS, Flores EJ. Accuracy and timeliness of an abbreviated emergency department MRCP protocol for choledocholithiasis. Emerg Radiol. 2019; 26: 427-32.
30
Malekzadeh S, Cannella R, Fournier I, Hiroz P, Mottet C, Constantin C, et al. The diagnostic value of abbreviated MRI protocol in the surveillance of Branch-Duct intraductal papillary mucinous neoplasm. Eur J Radiol. 2024; 175: 111455.
31
Prabhakar PD, Prabhakar AM, Prabhakar HB, Sahani D. Magnetic resonance cholangiopancreatography of benign disorders of the biliary system. Magn Reson Imaging Clin N Am. 2010; 18: 497-514, xi.
32
Sodickson A, Mortele KJ, Barish MA, Zou KH, Thibodeau S, Tempany CM. Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques. Radiology. 2006; 238: 549-59.
33
Yoen H, Lee JM, Lee SM, Kang HJ, Bae JS, Kim E, et al. Comparisons between image quality and diagnostic performance of 2D- and breath-hold 3D magnetic resonance cholangiopancreatography at 3T. Eur Radiol. 2021; 31: 8399-407.
34
Xue H, He M, Liu Z, Zhao X, Chen M, Jin Z. Chinese expert recommendation of scanning protocol and clinical application of magnetic resonance cholangiopancreatography. Chin J Acad Radiol. 2022; 6: 1-6.
35
Morita S, Ueno E, Masukawa A, Suzuki K, Machida H, Fujimura M, et al. Comparison of SPACE and 3D TSE MRCP at 1.5T focusing on difference in echo spacing. Magn Reson Med Sci. 2009; 8: 101-5.
36
Morita S, Ueno E, Suzuki K, Machida H, Fujimura M, Kojima S, et al. Navigator-triggered prospective acquisition correction (PACE) technique vs. conventional respiratory-triggered technique for free-breathing 3D MRCP: an initial prospective comparative study using healthy volunteers. J Magn Reson Imaging. 2008; 28: 673-7.
37
Nam JG, Lee JM, Kang HJ, Lee SM, Kim E, Peeters JM, et al. GRASE revisited: breath-hold three-dimensional (3D) magnetic resonance cholangiopancreatography using a Gradient and Spin Echo (GRASE) technique at 3T. Eur Radiol. 2018; 28: 3721-8.
38
Zhu L, Xue H, Sun Z, Qian T, Weiland E, Kuehn B, et al. Modified breath-hold compressed-sensing 3D MR cholangiopancreatography with a small field-of-view and high resolution acquisition: clinical feasibility in biliary and pancreatic disorders. J Magn Reson Imaging. 2018; 48: 1389-99.
39
Mannes I, Dallongeville A, Badat N, Beaussier H, Chatellier G, Zins M. Breath-hold compressed-sensing 3D MR cholangiopancreatography compared to free-breathing 3D MR cholangiopancreatography: prospective study of image quality and diagnostic performance in pancreatic disorders. Abdom Radiol (NY). 2020; 45: 1082-91.
40
Chen Z, Xue Y, Wu Y, Duan Q, Zheng E, He Y, et al. Feasibility of 3D breath-hold MR cholangiopancreatography with a spatially selective radiofrequency excitation pulse: prospective comparison with parallel imaging technique and compressed sensing method. Acad Radiol. 2022; 29: e289-95.
41
Brendel JM, Dehdab R, Herrmann J, Ursprung S, Werner S, Almansour H, et al. Deep learning reconstruction for accelerated 3-D magnetic resonance cholangiopancreatography. Radiol Med. 2025; 130: 714-22.
42
Kim J, Nickel MD, Knoll F. Deep learning-based accelerated MR cholangiopancreatography without fully-sampled data. NMR Biomed. 2025; 38: e70002.
43
Kim B, Park SH, Choi MH. Fast MRI techniques of the liver and pancreaticobiliary tract: overview and application. J Korean Soc Radiol. 2025; 86: 307-20.
44
Tajima T, Akai H, Sugawara H, Yasaka K, Kunimatsu A, Yoshioka N, et al. Breath-hold 3D magnetic resonance cholangiopancreatography at 1.5 T using a deep learning-based noise-reduction approach: comparison with the conventional respiratory-triggered technique. Eur J Radiol. 2021; 144: 109994.
45
Chevallier O, Escande H, Ambarki K, Weiland E, Kuehn B, Guillen K, et al. Single-breath-hold MRI-SPACE cholangiopancreatography with compressed sensing versus conventional respiratory-triggered MRI-SPACE cholangiopancreatography at 3Tesla: comparison of image quality and diagnostic confidence. Diagnostics (Basel). 2021; 11: 1886.
46
Yoon JH, Lee SM, Kang HJ, et al. Clinical feasibility of 3-dimensional magnetic resonance cholangiopancreatography using compressed sensing: comparison of image quality and diagnostic performance. Invest Radiol. 2017; 52: 612-9.
47
Jang W, Song JS, Kim SH, Yang JD. Comparison of compressed sensing and gradient and spin-echo in breath-hold 3D MR cholangiopancreatography: qualitative and quantitative analysis. Diagnostics (Basel). 2021; 11: 634.
48
Choi BI, Lee JM. Magnetic resonance cholangiopancreatography. In: Kamel IR, Merkle EM, editors. Body MR Imaging at 3 Tesla. 1st ed. Cambridge: Cambridge University Press; 2011. p. 123-33.
49
Zins M. Breath-holding 3D MRCP: the time is now? Eur Radiol. 2018; 28: 3719-20.
50
Arrivé L, Hodoul M, Arbache A, Slavikova-Boucher L, Menu Y, El Mouhadi S. Magnetic resonance cholangiography: current and future perspectives. Clin Res Hepatol Gastroenterol. 2015; 39: 659-64.
51
Yeh BM, Liu PS, Soto JA, Corvera CA, Hussain HK. MR imaging and CT of the biliary tract. Radiographics. 2009; 29: 1669-88.
52
Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics. 2009; 29: 1725-48.
53
Gupta RT, Brady CM, Lotz J, Boll DT, Merkle EM. Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents. AJR Am J Roentgenol. 2010; 195: 405-13.
54
Lee NK, Kim S, Lee JW, Lee SH, Kang DH, Kim GH, et al. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics. 2009; 29: 1707-24.
55
Santosh D, Goel A, Birchall IW, Kumar A, Lee KH, Patel VH, Low G. Evaluation of biliary ductal anatomy in potential living liver donors: comparison between MRCP and Gd-EOB-DTPA-enhanced MRI. Abdom Radiol (NY). 2017; 42: 2428-35.
56
Krishnan P, Gupta RT, Boll DT, Brady CM, Husarik DB, Merkle EM. Functional evaluation of cystic duct patency with Gd-EOB-DTPA MR imaging: an alternative to hepatobiliary scintigraphy for diagnosis of acute cholecystitis? Abdom Imaging. 2012; 37: 457-64.
57
Akpinar E, Turkbey B, Karcaaltincaba M, Balli O, Akkapulu N, Balas S, et al. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis. J Magn Reson Imaging. 2009; 30: 578-85.
58
Itani M, Lalwani N, Anderson MA, Arif-Tiwari H, Paspulati RM, Shetty AS. Magnetic resonance cholangiopancreatography: pitfalls in interpretation. Abdom Radiol (NY). 2023; 48: 91-105.
59
Griffin N, Yu D, Alexander Grant L. Magnetic resonance cholangiopancreatography: pearls, pitfalls, and pathology. Semin Ultrasound CT MR. 2013; 34: 32-43.
60
Kim SY, Park SH, Wu EH, Wang ZJ, Hope TA, Chang WC, et al. Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses. AJR Am J Roentgenol. 2015; 204: 1220-7.
61
Sundaram KM, Morgan MA, Itani M, Thompson W. Imaging of benign biliary pathologies. Abdom Radiol (NY). 2023; 48: 106-26.
62
Anderson SW, Lucey BC, Varghese JC, Soto JA. Accuracy of MDCT in the diagnosis of choledocholithiasis. AJR Am J Roentgenol. 2006; 187: 174-80.
63
Anderson SW, Rho E, Soto JA. Detection of biliary duct narrowing and choledocholithiasis: accuracy of portal venous phase multidetector CT. Radiology. 2008; 247: 418-27.
64
Uyeda JW, Richardson IJ, Sodickson AD. Making the invisible visible: improving conspicuity of noncalcified gallstones using dual-energy CT. Abdom Radiol (NY). 2017; 42: 2933-9.
65
Afzalpurkar S, Giri S, Kasturi S, Ingawale S, Sundaram S. Magnetic resonance cholangiopancreatography versus endoscopic ultrasound for diagnosis of choledocholithiasis: an updated systematic review and meta-analysis. Surg Endosc. 2023; 37: 2566-73.
66
Kondo S, Isayama H, Akahane M, Toda N, Sasahira N, Nakai Y, et al. Detection of common bile duct stones: comparison between endoscopic ultrasonography, magnetic resonance cholangiography, and helical-computed-tomographic cholangiography. Eur J Radiol. 2005; 54: 271-5.
67
Lopes Vendrami C, Thorson DL, Borhani AA, Mittal PK, Hammond NA, Escobar DJ, et al. Imaging of biliary tree abnormalities. Radiographics. 2024; 44: e230174.
68
Katabathina VS, Dasyam AK, Dasyam N, Hosseinzadeh K. Adult bile duct strictures: role of MR imaging and MR cholangiopancreatography in characterization. Radiographics. 2014; 34: 565-86.
69
Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology. 2004; 233: 234-40.
70
Suthar M, Purohit S, Bhargav V, Goyal P. Role of MRCP in differentiation of benign and malignant causes of biliary obstruction. J Clin Diagn Res. 2015; 9: TC08-12.
71
Wang GX, Ge XD, Zhang D, Chen HL, Zhang QC, Wen L. MRCP combined with CT promotes the differentiation of benign and malignant distal bile duct strictures. Front Oncol. 2021; 11: 683869.
72
Allard R, Smith C, Zhong J, Sheridan M, Guthrie A, Albazaz R. Imaging post liver transplantation part II: biliary complications. Clin Radiol. 2020; 75: 854-63.
73
Ryu CH, Lee SK. Biliary strictures after liver transplantation. Gut Liver. 2011; 5: 133-42.
74
Abdallah AA, Krige JE, Bornman PC. Biliary tract obstruction in chronic pancreatitis. HPB (Oxford). 2007; 9: 421-8.
75
Yam BL, Siegelman ES. MR imaging of the biliary system. Radiol Clin North Am. 2014; 52: 725-55.
76
Venkatesh SK, Welle CL, Miller FH, Jhaveri K, Ringe KI, Eaton JE, et al. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol. 2022; 32: 923-37.
77
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol. 2022; 77: 761-806.
78
Weismüller TJ, Trivedi PJ, Bergquist A, et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology. 2017; 152: 1975-84.e8.
79
Ito K, Mitchell DG, Outwater EK, Blasbalg R. Primary sclerosing cholangitis: MR imaging features. AJR Am J Roentgenol. 1999; 172: 1527-33.
80
Morgan MA, Khot R, Sundaram KM, Ludwig DR, Nair RT, Mittal PK, et al. Primary sclerosing cholangitis: review for radiologists. Abdom Radiol (NY). 2023; 48: 136-50.
81
Madhusudhan KS, Das P, Gunjan D, Srivastava DN, Garg PK. IgG4-related sclerosing cholangitis: a clinical and imaging review. AJR Am J Roentgenol. 2019; 213: 1221-31.
82
Zacarias MS, Pria HRFD, de Oliveira RAS, Delmonte LF, Velloni FG, D’Ippolito G. Non-neoplastic cholangiopathies: an algorithmic approach. Radiol Bras. 2020; 53: 262-72.
83
Martínez-de-Alegría A, Baleato-González S, García-Figueiras R, Bermúdez-Naveira A, Abdulkader-Nallib I, Díaz-Peromingo JA, et al. IgG4-related disease from head to toe. Radiographics. 2015; 35: 2007-25.s
84
Besa C, Cruz JP, Huete A, Cruz F. Portal biliopathy: a multitechnique imaging approach. Abdom Imaging. 2012; 37: 83-90.
85
Onoyama T, Takeda Y, Yamashita T, Hamamoto W, Sakamoto Y, Koda H, et al. Programmed cell death-1 inhibitor-related sclerosing cholangitis: a systematic review. World J Gastroenterol. 2020; 26: 353-65.
86
Ludwig DR, Anderson MA, Itani M, Sharbidre KG, Lalwani N, Paspulati RM. Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis. Abdom Radiol (NY). 2023; 48: 151-65.
87
Shroff GS, Strange CD, Ahuja J, Altan M, Sheshadri A, Unlu E, et al. Imaging of immune checkpoint inhibitor immunotherapy for non-small cell lung cancer. Radiographics. 2022; 42: 1956-74.
88
O’Brien C, Malik M, Jhaveri K. MR imaging in primary sclerosing cholangitis and other cholangitis. Radiol Clin North Am. 2022; 60: 843-56.
89
Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009; 29: 683-700.
90
Joo I, Lee JM, Yoon JH. Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges. Radiology. 2018; 288: 7-13.
91
Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975; 140: 170-8.
92
Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001; 234: 507-17; discussion 517-9.
93
Sahani DV, Shah ZK, Catalano OA, Boland GW, Brugge WR. Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol. 2008; 23: 23-33.
94
Jha P, Yeh BM, Zagoria R, Collisson E, Wang ZJ. The role of MR imaging in pancreatic cancer. Magn Reson Imaging Clin N Am. 2018; 26: 363-73.
95
Chen FM, Ni JM, Zhang ZY, Zhang L, Li B, Jiang CJ. Presurgical evaluation of pancreatic cancer: a comprehensive imaging comparison of CT versus MRI. AJR Am J Roentgenol. 2016; 206: 526-35.
96
Treadwell JR, Zafar HM, Mitchell MD, Tipton K, Teitelbaum U, Jue J. Imaging tests for the diagnosis and staging of pancreatic adenocarcinoma: a meta-analysis. Pancreas. 2016; 45: 789-95.
97
Sahni VA, Mortele KJ. Magnetic resonance cholangiopancreatography: current use and future applications. Clin Gastroenterol Hepatol. 2008; 6: 967-77.
98
Kim JH, Kim MJ, Chung JJ, Lee WJ, Yoo HS, Lee JT. Differential diagnosis of periampullary carcinomas at MR imaging. Radiographics. 2002; 22: 1335-52.
99
Liu J, Huang M, Ren Y, Xu M, Zhu J, Li Y, et al. Added value of zoomed-echo-planar imaging diffusion-weighted imaging for evaluation of periampullary carcinomas. Abdom Radiol (NY). 2023; 48: 3079-90.
100
Menias CO, Surabhi VR, Prasad SR, Wang HL, Narra VR, Chintapalli KN. Mimics of cholangiocarcinoma: spectrum of disease. Radiographics. 2008; 28: 1115-29.
101
Pedrosa I, Saíz A, Arrazola J, Ferreirós J, Pedrosa CS. Hydatid disease: radiologic and pathologic features and complications. Radiographics. 2000; 20: 795-817.
102
Erden A, Ormeci N, Fitoz S, Erden I, Tanju S, Genç Y. Intrabiliary rupture of hepatic hydatid cysts: diagnostic accuracy of MR cholangiopancreatography. AJR Am J Roentgenol. 2007; 189: W84-9.
